Velocity11 announces automation of cell-based Elisa

By Wai Lang Chu

- Last updated on GMT

Related tags Dna

Velocity11 has announced a new configuration of its BioCel
sample-processing platform that will allow all cell-based Elisa
procedures to become fully automated, reducing the risk of human
error, contamination and time spent on tedious procedures.

The new BioCel configuration dispenses cells into microplates and performs a series of alternating incubations and reagent additions ensuring a smooth and reliable operation in the handling of cells in automated systems.

The configuration is just one of a number that the BioCel platform can adapt to with the system ideally suited to complex assay formats due to its scheduling software, Liquid Handling options and the ability to integrate third-party instruments.

In integrating a VPrep pipetting station, a plate washer, CO2 Incubator and microplate absorbance reader the BioCel system can use VWorks software and scheduler to provide unattended automation of approximately 500 plates per run in a three-day experiment.

In addition, cells can be plated and stored at a rate of one minute/plate.

"The BioCel is one of the most compact and rapid automated sample processing systems on the market,"​ the company said.

BioCel is capable of configuring to a wide range of applications that include compound plate storage and replication, compound tube and plate replication, DNA purification and sequencing, flexible HTS system, kinase assay making it suitable for drug discovery research and nucleic acid sample preparation in Genomics laboratories.

For information on the BioCel series and the available BioCel system configurations, visit Velocity11's website.

Related topics Preclinical Research

Related news

Show more

Follow us


View more